« Return to News Archives

URAC Commentary: Pharmacists Play Critical Role Under MACRA

Wednesday, July 27th, 2016

“Adapt or face extinction.” That’s the stark advice URAC President and CEO Kylanne Green has for pharmacists wondering how things will change as the American health care system meets the demand for more value-based care under the Medicare Access and CHIP Reauthorization Act (MACRA).

In a commentary recently featured on the Drug Channels web site, Green noted physicians are the primary focus of MACRA’s fundamental change in how providers are reimbursed by Medicare. The role of pharmacists, however, will evolve as well. “While MACRA may not directly impact pharmacies today, the future of value-based payment envisioned by Congress and crafted by [the Center for Medicare and Medicaid Services] certainly will,” Green wrote. “Pharmacists and pharmacies that begin to adopt fundamental elements of the new value economy, those who position themselves as an essential part of the care team, will succeed. Those who don’t are likely to lose out.”

“Medication adherence and medication management are essential for driving health outcomes,” she added. “Now they will be driving payment. The trend in payers and drug manufacturers adopting value-based payment has begun in earnest.”

For insight into how pharmacies and pharmacists can demonstrate their value and position themselves as vital to patient management, read the entire commentary – “MACRA: What Value-Based Payment Means to Pharmacists” – on the Drug Channels web site.

Interested in accreditation?
Contact businessdevelopment@urac.org

Code of Conduct | Privacy Policy | Terms of Use

Social Media TextFollow us on FacebookFollow us on TwitterFollow us on Linked In